| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/09/2007 | US20070185082 Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane |
| 08/09/2007 | US20070185071 a compound containing cyclic tetrapeptide coupled to amide, ester, ketone groups; apoptosis and cell differentiation inducer; cancer metastasis and angiogenesis inhibitor; catalytic hydrogenation, acid treatment, fluoride anion treatment, or hydrolysis for deblocking; coupling cyclic tertrapeptide |
| 08/09/2007 | US20070185059 Antiallergic agents |
| 08/09/2007 | US20070185030 Immune response suppressor and treatment of multiple sclerosis |
| 08/09/2007 | US20070184477 Anti-HIV Agent |
| 08/09/2007 | US20070184435 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/09/2007 | US20070184091 Animal feed composition |
| 08/09/2007 | US20070184090 PUFA supplements |
| 08/09/2007 | US20070184064 Chimeric peptide immunogens |
| 08/09/2007 | US20070184061 Indolylmaleimide derivatives |
| 08/09/2007 | US20070184058 Glucocerebroside treatment of pulmonary or respiratory diseases or disorders |
| 08/09/2007 | US20070184022 Microsome vaccine |
| 08/09/2007 | US20070183983 Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same |
| 08/09/2007 | US20070183974 Method and apparatus for production of a skin graft and the graft produced thereby |
| 08/09/2007 | DE102006005404A1 Medicament, useful e.g. for prophylaxis, suppression or elimination of allergic reaction in humans, comprises gram-positive bacteria (Lactobacillus or Bifidobacterium) as essential active component |
| 08/09/2007 | CA2640661A1 Domain antibody construct |
| 08/09/2007 | CA2640277A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists |
| 08/09/2007 | CA2622679A1 Immunostimulatory single-stranded ribonucleic acid with phosphodiester backbone |
| 08/08/2007 | EP1816138A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 08/08/2007 | EP1816123A1 Intermediates for the production of pharmaceutically active compounds |
| 08/08/2007 | EP1814883A1 Bicyclic inhibitors or rho kinase |
| 08/08/2007 | EP1814878A1 Spiro-2, 4-pyrimidinediamine compounds and their uses |
| 08/08/2007 | EP1814516A1 Use of a liquid allergy vaccine formulation for oromucosal administration |
| 08/08/2007 | EP1689754B1 42-o-alkoxyalkyl rapamycin derivatives and compositions comprising same |
| 08/08/2007 | EP1678180B1 Substituted 2h-[1,2,4]triazolo 4,3-a pyrazines as gsk-3 inhibitors |
| 08/08/2007 | EP1615656B1 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same |
| 08/08/2007 | EP1611121B1 Pyridazinone derivatives as cdk2-inhibitors |
| 08/08/2007 | EP1482938B1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist |
| 08/08/2007 | EP1324992B1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 08/08/2007 | EP1255752B1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/08/2007 | EP0837129B1 Epimorphin antagonist and process for producing the same |
| 08/08/2007 | CN1330765C Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 08/08/2007 | CN1330754C Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity |
| 08/08/2007 | CN1330748C Bacterial protection |
| 08/08/2007 | CN1330657C Novel piperidine and piperazine derivatives |
| 08/08/2007 | CN1330654C Fused bicyclic pyrimidine derivatives |
| 08/08/2007 | CN1330638C Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them |
| 08/08/2007 | CN1330377C Peptide-base immunotherapeutic agent for allergic diseases |
| 08/08/2007 | CN1330336C Immune regulation oral liquid |
| 08/08/2007 | CN1330317C Composite immunopotentiator used for flounder baby fish |
| 08/08/2007 | CN1330307C Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/08/2007 | CN1330296C Propolis soft capsule and its preparation method |
| 08/08/2007 | CN101014708A Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1 |
| 08/08/2007 | CN101014623A Dr5抗体及其用途 Dr5 antibodies and their use |
| 08/08/2007 | CN101014597A Azaindoles useful as inhibitors of rock and other protein kinases |
| 08/08/2007 | CN101014596A Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides |
| 08/08/2007 | CN101012197A Method of synthesizing 5-(4-chloro-phenyl)-N-hydroxy-1-(4-methoxy-phenyl)-N-methyl-1H-pyrazole-3-propionamide and pharmaceutical use |
| 08/08/2007 | CN101011584A Method for achieving persistent transgene expression |
| 08/08/2007 | CN101011576A Compositions and methods for treating or preventing inflammatory diseases |
| 08/08/2007 | CN101011574A Use of an anti-il6 receptor antibody for preparing pharmaceutical composition |
| 08/08/2007 | CN101011573A Production of high molecular mass lectins |
| 08/08/2007 | CN101011568A Immuno-modulatory agents with function of preventing and curing type 2 diabetes |
| 08/08/2007 | CN101011486A Medicine for treating gynecological inflammation disease and its preparation process |
| 08/08/2007 | CN101011457A Traditional Chinese medicine composition with immunological enhancement function |
| 08/08/2007 | CN101011449A Method for preparing purple sweet potato granule |
| 08/08/2007 | CN101011419A Bee glue preparation and its preparation method |
| 08/08/2007 | CN101011362A Dispersible tablet of pidotimod and its preparing process and use |
| 08/08/2007 | CN101011185A Hybrid health cigarette |
| 08/08/2007 | CN101011145A Edible Collybia albuminosa(Berk.) Petch stuffing |
| 08/08/2007 | CN101011097A Herb tea compositions |
| 08/08/2007 | CN101011084A Milk for regulating organism immunity and its preparation |
| 08/07/2007 | USRE39762 e.g. 13-desmethoxy-18-hydroxyl-FK-520; compounds of the invention may be administered to achieve immunosuppression or to stimulate nerve growth and regeneration |
| 08/07/2007 | US7253341 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 08/07/2007 | US7253284 Chemical compounds |
| 08/07/2007 | US7253270 Polynucleotide encoding a mutated HIV gp41 polypeptide |
| 08/07/2007 | US7253199 Azole derivatives and pharmaceutical compositions containing them |
| 08/07/2007 | US7253194 Compounds and inhibitors of phospholipases |
| 08/07/2007 | US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/07/2007 | US7253189 1-aminoindane derivatives, e.g., 1-(cyclopentylcarbonylamino)-5-(4-cyclopropyl-2-(phenylsulfonyl)phenylsulfonyl)indane; exhibit anti-inflammatory and immunomodulatory activity |
| 08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
| 08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
| 08/07/2007 | US7253167 Tricyclic-heteroaryl compounds useful as kinase inhibitors |
| 08/07/2007 | US7253159 Antigen and lysine acylated protein; cytokines; drug screening; liquid chromatography |
| 08/07/2007 | US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other |
| 08/07/2007 | US7253151 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 08/07/2007 | US7252997 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 08/07/2007 | US7252845 Synergistic compositions containing aromatic compounds and terpenoids present in Alpinia galanga |
| 08/07/2007 | US7252825 MAGE-3 peptides presented by HLA class II molecules |
| 08/07/2007 | CA2381770C Human ctla-4 antibodies and their uses |
| 08/07/2007 | CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 08/07/2007 | CA2332007C Adenosine a3 receptor modulators |
| 08/07/2007 | CA2207804C Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
| 08/07/2007 | CA2192360C Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme |
| 08/07/2007 | CA2092718C Use of protective agents against reactive oxygen species |
| 08/02/2007 | WO2007086573A1 Agent for preventing or improving disease caused by candida infection and oral composition |
| 08/02/2007 | WO2007085652A1 Use of the (s) enantiomer of mequitazine for preparing a medicament, while at the same time limiting genomic toxicity |
| 08/02/2007 | WO2007085451A2 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti -inflammatory agents |
| 08/02/2007 | WO2007085057A1 A medical protocol |
| 08/02/2007 | WO2007054151A3 Use of chorionic gonadotropin as an immunosuppressor |
| 08/02/2007 | WO2007052073A3 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179192 Thrombopoietin mimetics |
| 08/02/2007 | US20070179183 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 08/02/2007 | US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 08/02/2007 | US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 08/02/2007 | US20070179101 biodrug as antitumor agent, a vaccine adjuvant for infections and cancers, and antiallergy agents |
| 08/02/2007 | US20070179087 Method for treating inflammatory diseases using heat shock proteins |
| 08/02/2007 | US20070178551 Methods for producing modified glycoproteins |